Oral Corticosteroid Prescribing for Children With Asthma in a Medicaid Managed Care Program

Harold J Farber1,2,3, Edwin A Silveira4, Douglas R Vicere4

  • 1Section of Pulmonology and hjfarber@texaschildrens.org.

Pediatrics
|May 31, 2017
PubMed

Insights

Oral corticosteroid (OCS) overuse is common in children with asthma, particularly in those aged 1-4 years. Most OCS prescriptions were not associated with indicators of poor asthma control, suggesting overprescribing.

Area of Science:

  • Pediatric Pulmonology
  • Pharmacology
  • Health Services Research

Background:

  • Short courses of oral corticosteroids (OCS) are recommended for moderate to severe asthma exacerbations.
  • Concerns exist regarding the overuse of OCS in pediatric asthma management.
  • Understanding OCS dispensing patterns is crucial for optimizing treatment.

Purpose of the Study:

  • To determine the rates of OCS dispensing in children with asthma.
  • To identify factors associated with variations in OCS dispensing.
  • To assess the appropriateness of OCS prescribing in pediatric asthma.

Main Methods:

  • Analysis of claims data from Texas Children's Health Plan for children aged 1 to <18 years with an asthma diagnosis (2011-2016).
  • Examination of OCS dispensing rates and associated demographic and clinical factors.
  • Comparison of OCS prescribing patterns across different primary care providers and individual pediatricians.

Main Results:

  • Between 42.1% and 44.2% of children with asthma received at least one OCS dispensing annually from 2011-2015.
  • Younger children (1-4 years) had higher OCS dispensing rates, with frequent repeat dispensing.
  • Most OCS dispensings lacked indicators of poor asthma control, and prescribing varied significantly among pediatricians.

Conclusions:

  • Observed OCS dispensing patterns indicate substantial overprescribing in children with asthma.
  • Targeted interventions may be needed to reduce unnecessary OCS use.
  • Further research should explore strategies for appropriate asthma management and OCS stewardship.
Abstract

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.8K
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
912
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
960
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.9K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K